Past Gallery
1-408-352-1010, +44-203-807-2454

WHAT ABOUT EVENT

International Pharma Research & Drug Delivery Summit ( IPRDS 2019) will take place in the gorgeous city of Brussels, Belgium in June10-12, 2019 and the theme of the conference is “A Global Review and Forecast on Pharma R&D”. Pharma Research & Drug delivery Summit is the leading platform bringing together all professionals, industry experts, and academia in Pharmaceutics & formulations, Drug Development and Delivery. 

Mark your calendars now and for more details please contact us at pharma@iprds.org

about

WHO WE ARE?

Innovinc Organization is a professional conference organizer, established for over 3 years and organized more than 50 conferences from all over the world. We specialize in organizing large international conferences in the fields of Life Science, Pharma, Medical and Engineering and Technology.

about

WHAT WE DO?

Our conferences are about you, our clients, so we work for unqualified success and we do that quietly, professionally and impeccably. We've built a reputation for creating and delivering inspirational conferences and executing them flawlessly first time around. We work really hard to achieve this and our success is down to the dynamics of a team who are down-to-earth.

about

WHY US?

INNOVINC conferences cover a broad range of research in the area of life science and technology. Attending an Innovinc Conference will provide immense access to ground-breaking research presentations and discussions which provides the best break to develop collaborations, get innovative ideas and opportunities for your own work.

About Conference

Pharma Research & Drug delivery Summit (IPRDS 2019) is the leading platform bringing together all professionals, industry experts, and academia in Pharmaceutics & formulations, Drug Development and Delivery. IPRDS 2019 creates a unique platform to discuss the challenges and showcase the latest technologies in the formulation and drug delivery to improve solubility, stability, and bioavailability of Drugs, enhance the drug design and fasten the Drug development process.

This is your opportunity to learn from formulation, development and Drug Delivery thought leaders and experts in Industry and academia focusing on Small Molecules, Biologics, and Technology & Innovation and discuss their impact on product enhancement and patient experience.

The conference will be packed with presentations, talks, real-time case studies, workshops, and panel and roundtable discussions with plenty of networking opportunities. There will be poster presentation and Award Function to recognize innovation in Drug Formulation and Delivery technologies.

DOWNLOAD BROCHURE
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home
  • slider-home

Scientific Sessions

Conference sessions may be geared toward participants with different levels of experience or different positions. Main conference sessions include the following tracks. Choose to follow one track or move between tracks to create your own personalized conference experience.

Why to Attend

Innovinc International welcomes you to attend the International Pharma Research & Drug Delivery Summit during June 10 - 12, 2019 at Brussels, Belgium. To meet renowned speakers, the world's leading CEO's, Directors, decision and policymakers, to know about the ongoing research projects in the field of Pharma. To keep abreast of all advances in Pharma R&D. Chance to collaborate with research organizations with industries and to share the research ideas and implement them in Pharma research. Best opportunity to reach the largest assemblage of participants from Pharma Societies.

 

VIEW ALL SPEAKERS

CONFERENCE AGENDA

day 1 agenda

Mon , Jun 10, 2019

  • 08:00
  • Registrations

  • 08:45
  • Opening Ceremony & Welcome Speech

  • 09:00
  • Keynote Talk-1 : 3D Printed Corneal Equivalent

    Sachdeva Mandip S, Florida A&M University, USA

  • 09:30
  • Keynote Talk-2 : Use of Cyclodextrin as a Novel Agent in the SEC-HPLC Mobile Phase to Mitigate the Interactions of Proteins or Peptide or their Impurities with the Residual Silanols of Commercial SEC-HPLC Columns with Improved Separation and Resolution.

    Kaliappanadar Nellaiappan, Curirx inc, USA

  • 10:00
  • Keynote talk-3 : Preparation and nanoformulation of new quinolone scaffold-based anticancer agents: Enhancing solubility for better cellular delivery

    Reem K. Arafa, Zewail City of Science and Technology, Egypt

  • 10:30
  • Keynote Talk-4: Lung Delivery of Biopharmaceuticals using Nanocarrier Systems

    Imran Saleem, Liverpool John Moores University, UK

  • 11:00
  • Refreshment Break @ Foyer

  • 11:20
  • Scientific Session : High gene delivery efficiency mediated by lipid- and polymer-based nanosystems

    Henrique Faneca, University of Coimbra, Portugal

  • 11:40
  • Scientific Session : Targeting c-MYC and c-MYC regulating microRNAs in ovarian cancer with liposomal-interference RNA

    Pablo Vivas-Mejia, University of Puerto Rico, Puerto Rico

  • 12:00
  • Scientific Session : Cell-based chemoresistance models to evaluate combinational nanoformuations

     Badiree Konkimalla, National Institute of Science Education and Research (NISER), India

  • 12:20
  • Scientific Session : Inorganic Nanomaterials as Carriers in Targeted Delivery of Anticancer Drugs

    R.M.G. Rajapakse, University of Peradeniya, Sri Lanka

  • 12:40
  • Scientific Session : Nanoparticle Engineering towards Highly Efficient Drug Delivery Systems and SERS-based Bio-Sensing

    Beatrice Fortuni, KU Leuven, Belgium

  • 13:00
  • Lunch @ Restarunt

  • 13:50
  • Scientific Session : The Importance of Modernization of Acetaminophen (Paracetamol) containing Documentary Standards to Global Public Health

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 14:10
  • Scientific Session : Marine Compound Xyloketal B as a Novel Drug Candidate for Cardiovascular and neuronal protection

    Guan-Lei Wang, Sun Yat-sen University, China

  • 14:30
  • Scientific Session : Amino acid based surfactants: A class of amphiphiles with potential applications in the pharmaceutical field

    Diego Romano Perinelli, University of Camerino, Italy

  • 14:50
  • Scientific Session : Development and Pharmacokinetic Evaluations of a Co-Solvent and a PLGA-based Nanospheres of Itraconazole for Intravenous Administrations

    Dong Liang, Texas Southern University, USA

  • 15:10
  • Scientific Session : Subcutaneous formulation of furosemide: endless opportunities for an old drug

    Tamas Alexy, University of Minnesota, USA

  • 15:30
  • Scientific Session : Treatment of animal model for hot flushes by nasal administration of a non-hormonal drug delivery system

    Hiba Natsheh, Hebrew University of Jerusalem, Israel

  • 15:50
  • Coffee Break @ Foyer

  • 16:10
  • Special Session: Phytochemical compounds of Selected Lebanese Plants with Potential Biological activities

    Maha Aboul-Ela, Faculty of Pharmacy, Beirut Arab University, Lebanon

  • 16:30
  • Special Session: Contribution of Developed Prototype Research Software Relevant to Infants’ Prakriti (Physical constitution) Assessment for Vikriti (Pathological condition) Management and Possible Future Disorders

    Srivastava Niraj, Government Ayurvedic PG College, India

  • 16:50
  • Special Session : Role of Leech Therapy in Different Diseases W.S.R. Deep vein Thrombosis (DVT)

    Varsha Saxena, Uttarakhand Ayurveda University (UAU), India

day 2 agenda

Tue , Jun 11, 2019

  • 08:30
  • Registrations

  • 09:00
  • Keynote Talk-1 : Bridging Discovery program to Development-The Making of a Phase I Trial Study

    Elizabeth Kwong, Kwong Eureka Solutions, Canada

  • 09:40
  • Keynote talk-2 : Material properties impacting micronization behavior of a crystalline drug

    Ajit Narang, Genentech Inc., USA

  • 10:10
  • Keynote talk-3 : Development of a novel anti-Ran-GTPase peptide nanoparticles as a novel approach for antimetastatic therapies

    Ahmed Faheem, University of Sunderland, UK

  • 10:40
  • Keynote talk-4 : Development of integrated enzymatic electrophoretic methodologies for the quality control of therapeutic biomolecules

    Catherine Perrin, University of Montpellier, France

  • 11:10
  • Coffee Break @ Foyer

  • 11:30
  • Scientific Session : Biorelevant Dissolution to Facilitate Formulation Development of a BSC Class 2 Basic Compound and Overcome Drug-Drug Interaction with Acid Reducing Agents

    Dawen Kou, Genentech, USA

  • 11:50
  • Scientific Session : Our smeared FE computational models for drug delivery in organs and tumors

    Milos Kojic, Serbian Academy of Sciences and Arts, Serbia

  • 12:10
  • Scientific Session : Divorce uses of gabapentenoids and it’s implications- a new public health issue

    Shubhakaran Khichar, Dr. S. N. Medical College, India

  • 12:30
  • Scientific Session : Chiral HPLC Resolution of a Potentially Serious Global Health Crisis

    Clydewyn Anthony, United States Pharmacopeial Convention, USA

  • 12:50
  • Scientific Session : Patient Registries and the EU Regulatory Framework: Some Reflections

    Charlotte Ryckman, Covington & Burling LLP

  • 13:20
  • Lunch @ Restaurant

  • 14:10
  • Scientific Session : Precision Medicine Collaborations at the Industry- Academic Interface

    Patrick J Silva, University of Arizona Health Sciences, USA

  • 14:20
  • Scientific Session : A Pharmacokinetic Study of Medazolam and Ketamine in Patients on Extracorporeal Membrane Oxygenation Therapy

    Gagan Kaushal, Thomas Jefferson University, USA

  • 14:50
  • Scientific Session : Analysis 3-Hydroxypropyl Mercapturic Acid (3- HPMA) in Urine of Breast Cancer Patient for Monitoring the Toxicity of Cyclophosphamide

    Yahdiana Harahap, Universitas Indonesia, Indonesia

  • 15:10
  • Scientific Session : Bactericidal autophagy inhibitors in cancer treatment

    Benedetto Grimaldi, Italian Institute of Technology, Italy

  • 15:30
  • Scientific Session : In vitro lung epithelial cell transport and antiinterleukin- 8 releasing activity of liposomal ciprofloxacin

    Ruba S. Darweesh, Jordan University of Science and Technology, Jordan

  • 15:50
  • Scientific Session : Spiro-fused cyclopropa[a]pyrrolizines and 3-azabicyclo[3.1.0]hexanes as potential antitumor agents

    Vitali M Boitsov, Saint Petersburg Academic Universitry, Russia

  • 16:10
  • Scientific Session : 3D Bioprinting Substitute Encapsulated with Cells and Growth Factor

    Lei Nie, KU Leuven, Belgium

  • 16:30
  • Coffee Break @ Foyer

day 3 agenda

Wed , Jun 12, 2019

  • 10:00
  • Networking

  • 12:30
  • Lunch @ Restaurant 

Scientific Program Download

HURRY UP! ONLY 30 SEATS REMAINING CURRENTLY…

Don t Miss This Amazing Conference And Opportunities

Past Conference Gallery

Promote Partners